JP2020510680A5 - - Google Patents

Download PDF

Info

Publication number
JP2020510680A5
JP2020510680A5 JP2019548683A JP2019548683A JP2020510680A5 JP 2020510680 A5 JP2020510680 A5 JP 2020510680A5 JP 2019548683 A JP2019548683 A JP 2019548683A JP 2019548683 A JP2019548683 A JP 2019548683A JP 2020510680 A5 JP2020510680 A5 JP 2020510680A5
Authority
JP
Japan
Prior art keywords
dialysate
spiked
thiosulfate
pharmaceutical composition
subject
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2019548683A
Other languages
English (en)
Japanese (ja)
Other versions
JP7416622B2 (ja
JP2020510680A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2018/021069 external-priority patent/WO2018165108A1/en
Publication of JP2020510680A publication Critical patent/JP2020510680A/ja
Publication of JP2020510680A5 publication Critical patent/JP2020510680A5/ja
Priority to JP2024000105A priority Critical patent/JP7642878B2/ja
Application granted granted Critical
Publication of JP7416622B2 publication Critical patent/JP7416622B2/ja
Priority to JP2025028476A priority patent/JP2025084833A/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2019548683A 2017-03-08 2018-03-06 チオ硫酸ナトリウムの透析中の使用 Active JP7416622B2 (ja)

Priority Applications (2)

Application Number Priority Date Filing Date Title
JP2024000105A JP7642878B2 (ja) 2017-03-08 2024-01-04 チオ硫酸ナトリウムの透析中の使用
JP2025028476A JP2025084833A (ja) 2017-03-08 2025-02-26 チオ硫酸ナトリウムの透析中の使用

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201762468871P 2017-03-08 2017-03-08
US62/468,871 2017-03-08
PCT/US2018/021069 WO2018165108A1 (en) 2017-03-08 2018-03-06 Intradialytic use of sodium thiosulfate

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2024000105A Division JP7642878B2 (ja) 2017-03-08 2024-01-04 チオ硫酸ナトリウムの透析中の使用

Publications (3)

Publication Number Publication Date
JP2020510680A JP2020510680A (ja) 2020-04-09
JP2020510680A5 true JP2020510680A5 (enExample) 2021-04-22
JP7416622B2 JP7416622B2 (ja) 2024-01-17

Family

ID=63446695

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2019548683A Active JP7416622B2 (ja) 2017-03-08 2018-03-06 チオ硫酸ナトリウムの透析中の使用
JP2024000105A Active JP7642878B2 (ja) 2017-03-08 2024-01-04 チオ硫酸ナトリウムの透析中の使用
JP2025028476A Pending JP2025084833A (ja) 2017-03-08 2025-02-26 チオ硫酸ナトリウムの透析中の使用

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2024000105A Active JP7642878B2 (ja) 2017-03-08 2024-01-04 チオ硫酸ナトリウムの透析中の使用
JP2025028476A Pending JP2025084833A (ja) 2017-03-08 2025-02-26 チオ硫酸ナトリウムの透析中の使用

Country Status (15)

Country Link
US (5) US10744156B2 (enExample)
EP (2) EP3592824B1 (enExample)
JP (3) JP7416622B2 (enExample)
KR (4) KR102758644B1 (enExample)
AR (1) AR111236A1 (enExample)
AU (2) AU2018231072B2 (enExample)
BR (1) BR112019018646A2 (enExample)
CA (1) CA3055107A1 (enExample)
ES (1) ES2992792T3 (enExample)
IL (4) IL302827B2 (enExample)
NZ (1) NZ756704A (enExample)
PH (1) PH12019501971A1 (enExample)
TW (3) TWI789378B (enExample)
WO (1) WO2018165108A1 (enExample)
ZA (2) ZA202105781B (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2992792T3 (en) 2017-03-08 2024-12-18 Hope Medical Entpr Inc D B A Hope Pharmaceuticals Intradialytic use of sodium thiosulfate
MD3817751T2 (ro) 2018-07-03 2025-10-31 Fennec Pharmaceuticals Inc Compoziții de tiosulfat de sodiu anhidru
US11850313B2 (en) * 2019-12-20 2023-12-26 The London Health Sciences Centre Research Inc. Method and compositions for protecting tissue
WO2024092228A2 (en) * 2022-10-28 2024-05-02 University Of Pittsburgh - Of The Commonwealth System Of Higher Education Localized delivery of sodium thiosulfate nanoparticles to mitigate arterial calcification
CN116573782B (zh) * 2023-04-03 2023-11-03 迁安市宏奥工贸有限公司 脱硫废液的处理方法

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1341151C (en) 1985-09-10 2000-12-05 Elias Klein Osmotic agents form peritoneal dialysis
US5108767A (en) * 1991-06-10 1992-04-28 Abbott Laboratories Liquid nutritional product for persons receiving renal dialysis
US6380163B1 (en) 1992-12-22 2002-04-30 Baxter International Inc. Peritoneal dialysis solutions with polypeptides
FI98538C (fi) * 1993-10-20 1997-07-10 Enso Gutzeit Oy Menetelmä natriumhydroksidin valmistamiseksi valkolipeästä
US6306836B1 (en) 1994-01-21 2001-10-23 Baxter International Inc. Peritoneal dialysis solutions containing maltodextrins and amino acids
US6436969B1 (en) 1995-09-12 2002-08-20 Kansas University Medical Center Research Institute Inc. Dialysis solutions and methods
CA2422850C (en) * 1999-09-22 2009-03-03 Advanced Renal Technologies High citrate dialysate and uses thereof
CA2406081C (en) * 2000-04-26 2009-12-22 Oregon Health Sciences University Administration of a thiol-based chemoprotectant compound
JP4882054B2 (ja) 2000-09-13 2012-02-22 独立行政法人科学技術振興機構 腹膜透析液およびその調製法
CA2537222A1 (en) 2003-07-09 2005-01-27 The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Use of nitrite salts for the treatment of cardiovascular conditions
WO2006001345A1 (ja) 2004-06-23 2006-01-05 Kyowa Hakko Kogyo Co., Ltd. Ｌ－リジン・クエン酸塩結晶
US20070154570A1 (en) 2004-09-29 2007-07-05 Miller Christopher C Use of nitric oxide in the treatment and disinfection of biofilms
US7834065B2 (en) 2005-01-31 2010-11-16 Bmg Incorporated Medical-use two part reactive adhesive and medical-use resin having self-degradation property
US20090304600A1 (en) * 2008-06-09 2009-12-10 Anupkumar Shetty Intradialytic administration of sodium thiosulfate
US8568793B2 (en) 2009-02-11 2013-10-29 Hope Medical Enterprises, Inc. Sodium nitrite-containing pharmaceutical compositions
DK2451435T4 (da) 2009-07-08 2022-02-28 Hope Medical Entpr Inc D B A Hope Pharmaceuticals Natriumthiosulfat-indeholdende farmaceutiske sammensætninger
WO2013023217A1 (en) 2011-08-11 2013-02-14 Board Of Regents, The University Of Texas System Method of measuring and monitoring in vivo nitrite levels
AU2013212264B2 (en) 2012-01-23 2017-05-18 Santalis Pharmaceuticals Inc. Sandalwood oil and its uses related to clostridium infections
JP2015516407A (ja) * 2012-05-10 2015-06-11 アンスティチュ ナショナル ドゥ ラ サンテ エ ドゥ ラ ルシェルシュ メディカル 異所性石灰化の治療のためのチオ硫酸ナトリウム
JP5486069B1 (ja) * 2012-11-05 2014-05-07 旭 酒井 透析装置
US20140350097A1 (en) 2013-05-23 2014-11-27 Medinox,Inc. Treatment of hypotension associated with hemodialysis
WO2016094409A1 (en) * 2014-12-09 2016-06-16 Villarreal Anna Methods and devices for female health monitoring
ES2992792T3 (en) 2017-03-08 2024-12-18 Hope Medical Entpr Inc D B A Hope Pharmaceuticals Intradialytic use of sodium thiosulfate
IL301302B2 (en) 2017-03-08 2024-09-01 Hope Medical Entpr Inc Dba Hope Pharmaceuticals Intradialytic use of sodium nitrite

Similar Documents

Publication Publication Date Title
JP2020510680A5 (enExample)
JP2020510014A5 (enExample)
CN102985071B (zh) 透析前体组合物
Simpson et al. Ultrafiltration in the management of refractory congestive heart failure.
Langston et al. Applications and outcome of hemodialysis in cats: a review of 29 cases
US6610206B1 (en) Buffered compositions for dialysis
CN103796634B (zh) 透析前体组合物
Soussi et al. Chloride toxicity in critically ill patients: What's the evidence?
Borkan Extracorporeal therapies for acute intoxications
Hayes et al. Intradialytic hypotension
Ortega et al. Contrast-induced nephropathy: pathogenesis and new therapeutic options for prevention
Simpson et al. Ultrafiltration in diuretic-resistant cardiac failure
McCullough Prevention of cardiorenal syndromes
ES2862649T3 (es) Fluido de diálisis sin calcio
Borghi et al. Omega-3 fatty acids: A promising possible treatment for Meniere’s Disease and other inner ear disorders of unknown origin?
Skull Circulation-anatomy, physiology and pathophysiology
KR102244530B1 (ko) 뇌 및 전신의 재관류 손상을 예방하거나 감소시키기 위한 보호 용액
ES2724933A1 (es) Terapia combinada con melatonina para la reducción de la presión intraocular
Alwan et al. Intradialytic hypotension complication, in cardiac and non cardiac risky end stage renal disease (ESRD) patients
Leunissen et al. Acute dialysis complications
Maurya et al. Comparative Analysis Between Two Crystalloid Balanaced Electrolyte Priming Solution (plasmalyte-a And Sterofundin Iso) In Adult Patient Undergoing Cardioplulomnary Bypass In The Cardiac Surgery
Foringer et al. Potassium disorders
Thornhill et al. Current Status Of Hemodialysis In Veterinary Medicine And The Development Of The Canine Animal Model For Hemodialysis-Related Disorders In Man
FR2613228A1 (fr) Composition rehydratante a base de glucose utile notamment dans le traitement des etats diarrheiques et des etats de chocs chez le veau
เพชร วัชร สิน ธุ์ Is (ab) normal saline harmful?